purpose: Extended resections for NSCLC may improve survival in selected patients. However, the analysis on large series is still lacking. We reviewed our experience in order to identify prognostic factors usefull for patient's selection. methods: Between 1998 and 2010, 167 patients with one or more mediastinal organ involvement underwent surgery with the intent-to-perform extended resection. At thoracotomy 25% (42pts) were considered unresectable (exploratory thoracotomy \u2013 ET) and 75% (125 pts) underwent extended resection (ER). The types of ER were SVC in 43 (34,4%) patients, carina in 33 (26,4%), 18 (14,4%) combined with SVC, left atrium in 35 (28%), and aorta in 14 (11,2%). We excluded Pancoast tumors and vertebral resections. The m...
Objective: 10-Year survival (10YS) after radical surgery for non-small cell lung cancer (LC) patien...
Objective: We conducted a thorough literature search on patients with central non-small cell lung ca...
Objective: The early and local advanced stages (IA-IIIA) of non-small cell lung cancer (NSCLC) warra...
BACKGROUND: Extended resections (ER) for lung cancer may improve survival in selected patients. Howe...
Background: Extended resections (ER) for lung cancer may improve survival in selected patients. Howe...
BACKGROUND: Lung cancer invading outside a lobe centrally or peripherally, or presenting with synchr...
Objective: This retrospective study was conducted to investigate the impact of more extended mediast...
OBJECTIVE Surgical treatment of locally advanced non-small cell lung cancer including single or m...
Surgery is the mainstay treatment of non-small-cell lung cancer (NSCLC), but its impact on very-long...
Background: Few patients diagnosed with lung cancer are still alive 5 years after diagnosis. The aim...
Background: There are no international guidelines for an appropriate and cost-effective follow-up fo...
OBJECTIVE: the role of extended pulmonary resection for lung metastases is still unclear, and very p...
OBJECTIVE Surgical treatment of locally advanced non-small cell lung cancer including single or m...
OBJECTIVE:Overall survival (OS) for advanced stage (IIIA-IV) non-small cell lung cancer (NSCLC) is h...
Background Large cell neuroendocrine carcinomas (LCNEC) represent approximately 3% of all lung canc...
Objective: 10-Year survival (10YS) after radical surgery for non-small cell lung cancer (LC) patien...
Objective: We conducted a thorough literature search on patients with central non-small cell lung ca...
Objective: The early and local advanced stages (IA-IIIA) of non-small cell lung cancer (NSCLC) warra...
BACKGROUND: Extended resections (ER) for lung cancer may improve survival in selected patients. Howe...
Background: Extended resections (ER) for lung cancer may improve survival in selected patients. Howe...
BACKGROUND: Lung cancer invading outside a lobe centrally or peripherally, or presenting with synchr...
Objective: This retrospective study was conducted to investigate the impact of more extended mediast...
OBJECTIVE Surgical treatment of locally advanced non-small cell lung cancer including single or m...
Surgery is the mainstay treatment of non-small-cell lung cancer (NSCLC), but its impact on very-long...
Background: Few patients diagnosed with lung cancer are still alive 5 years after diagnosis. The aim...
Background: There are no international guidelines for an appropriate and cost-effective follow-up fo...
OBJECTIVE: the role of extended pulmonary resection for lung metastases is still unclear, and very p...
OBJECTIVE Surgical treatment of locally advanced non-small cell lung cancer including single or m...
OBJECTIVE:Overall survival (OS) for advanced stage (IIIA-IV) non-small cell lung cancer (NSCLC) is h...
Background Large cell neuroendocrine carcinomas (LCNEC) represent approximately 3% of all lung canc...
Objective: 10-Year survival (10YS) after radical surgery for non-small cell lung cancer (LC) patien...
Objective: We conducted a thorough literature search on patients with central non-small cell lung ca...
Objective: The early and local advanced stages (IA-IIIA) of non-small cell lung cancer (NSCLC) warra...